REMI
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 May 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98001768
- Mark type
- Stylized text
- Filed
- 17 May 2023
- Published for opposition
- 31 Mar 2026
- Attorney of record
- Steven John Hultquist
Goods and services
- Class 005 — Pharmaceuticals: antibiotic pharmaceuticals, anti-diabetic pharmaceuticals, antiviral pharmaceuticals, ocular pharmaceuticals, cardiovascular pharmaceuticals, pulmonary pharmaceuticals, bronchodilator pharmaceuticals, analgesic pharmaceuticals, muscle relaxant pharmaceuticals, hyperlipidemia pharmaceuticals, psychotropic pharmaceuticals, decongestant pharmaceuticals, weight loss pharmaceuticals, anticancer pharmaceuticals, antidepressant pharmaceuticals, vaccine pharmaceuticals, antihelmintic pharmaceuticals, antitussive pharmaceuticals, and anticoagulant pharmaceuticals; prescription medicines, namely, prescription pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases and for the treatment of diabetes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
- Class 044 — Medical, beauty and agricultural services: telemedicine services; telehealth services in the nature of telemedicine services; medical information services; medical information services provided via the Internet; providing medical information; prescription medicine refill reminder services; online pharmaceutical medication counseling and prescription services in the nature of preparation of prescriptions by pharmacists
Owner
- REMI INVESTMENT HOLDINGS, LLC, HENDERSON, NV, US
- REMI INVESTMENT HOLDINGS, LLC, HENDERSON, NV, US
- Celmatrix Corporation, Henderson, NV, US
Prosecution history
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 04 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 04 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 24 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION WRITTEN
- 04 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION